Chronic Myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by the presence of p210Bcr-Abl fusion protein with a constitutively active tyrosine kinase activity [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.